PERSPECTA

News from every angle

Back to headlines

Pakistan Faces Medicine Shortages and Counterfeiting Due to Pricing Delays

A delay by Pakistan's federal cabinet in deciding on medicine price revisions has led to severe shortages and increased risks of counterfeiting. The Drug Regulatory Authority of Pakistan (DRAP) had recommended price adjustments for 105 hardship-category medicines over two years ago.

13 Jul, 02:53 — 13 Jul, 02:53
PostShare